Advanced Systemic Mastocytosis clinical trials at University of California Health

1 research study open to eligible people

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
open to eligible people ages 18 years and up
This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patients with Aggressive SM (ASM), SM with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL).
at UCLA

Last updated: May 2025